Skip to content
Disclosery

Roubaix Capital, LLC: BIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Roubaix Capital, LLC on BIO, newest first. How the timeline and the estimate are built.

Roubaix Capital, LLC held 0 BIO shares at 2025-12-31 per its 13F-HR filed 2026-02-09.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -8,112 shares

    13F-HR 0001769700-26-000002 filed by Roubaix Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 8,112 shares
    Change vs previous 13F +8,112 shares

    1.06% of the 13F portfolio, value $2,274,524.

    13F-HR 0001769700-25-000009 filed by Roubaix Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -11,303 shares

    13F-HR 0001769700-25-000003 filed by Roubaix Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2024-12-31
    13F 11,303 shares
    Change vs previous 13F +11,303 shares

    1.78% of the 13F portfolio, value $3,713,149.

    13F-HR 0001769700-25-000002 filed by Roubaix Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 0 shares
    Change vs previous 13F not available

    13F-HR 0001104659-24-111489 filed by Roubaix Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.